Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-09-05), the Trailing Annual Dividend Yield of GeneReach Biotechnology is 0.00%.
The historical rank and industry rank for GeneReach Biotechnology's Dividend Yield % or its related term are showing as below:
During the past 13 years, the highest Dividend Yield of GeneReach Biotechnology was 11.78%. The lowest was 2.09%. And the median was 4.57%.
ROCO:4171's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.22 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4171 vs VRTX, REGN, MRNA: Dividend Yield % Comparison
For the Biotechnology subindustry, GeneReach Biotechnology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GeneReach Biotechnology Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, GeneReach Biotechnology's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where GeneReach Biotechnology's Dividend Yield % falls into.
GeneReach Biotechnology (ROCO:4171) has a Dividend Yield % of 0.00% as of Sep. 05, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on GeneReach Biotechnology and its competitors. Over the past decade, GeneReach Biotechnology's Dividend Yield % has ranged from 2.09 to 11.78. According to the industry distribution chart, GeneReach Biotechnology ranks #999999 out of 149 companies in the Biotechnology industry.
Is GeneReach Biotechnology's Dividend Yield % too high?
GeneReach Biotechnology's current Dividend Yield % is 0.00%. Over the past 10 years, this metric has ranged from a low of 2.09 to a high of 11.78. Based on the distribution chart, GeneReach Biotechnology ranks #999999 out of 149 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, GeneReach Biotechnology has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GeneReach Biotechnology's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, GeneReach Biotechnology ranks #999999 out of 149 companies for Dividend Yield %. This places GeneReach Biotechnology in the lower half of its industry. The industry median Dividend Yield % is 1.22. Historically, GeneReach Biotechnology's own Dividend Yield % has ranged from 2.09 to 11.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.22, based on 149 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on GeneReach Biotechnology and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GeneReach Biotechnology's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GeneReach Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, GeneReach Biotechnology (ROCO:4171) is currently considered Possible Value Trap. The stock's GF Value™ is NT$26.12, compared to a current price of NT$16.80 — trading 35.7% below its estimated fair value. The current Dividend Yield % is 0.00%. GeneReach Biotechnology's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For GeneReach Biotechnology (ROCO:4171), the current Dividend Yield % is 0.00% as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GeneReach Biotechnology (ROCO:4171) Overvalued in 2026?
Based on GuruFocus' analysis, GeneReach Biotechnology stock appears to be undervalued.
The current stock price of NT$16.80 is trading 35.7% below its estimated GF Value™ of NT$26.12.
GuruFocus considers GeneReach Biotechnology to be Possible Value Trap.
Key valuation signals for ROCO:4171:
Dividend Yield %: 0.00%
GF Value™: NT$26.12 vs. price of NT$16.80 (35.7% below fair value)
No single metric tells the full story. See the ROCO:4171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GeneReach Biotechnology Corp is a biotechnology company. The company develops, manufactures and markets products for applied nucleic acid detection technology. Its products are utilised for aquaculture, agriculture, food, companion animal, livestock and human health industries.
58GF Score
Get the complete analysis for ROCO:4171
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4171 has been successfully added to your 
